Arginine metabolism revisited

Journal of Nutrition

Volumn 146, Issue 12, 2016, Pages 2579S-2586S

  Morris, Sidney M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

ADMA; Arginase; Argininosuccinate; GPCR; Homoarginine; mTORC1; Nitric oxide

Indexed keywords

AGMATINE; ARGININE; CITRULLINE; CREATINE; GLUTAMIC ACID; HOMOARGININE; NITRIC OXIDE; POLYAMINE; PROLINE; UREA;

AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ARTICLE; CELL FUNCTION; CELL METABOLISM; ENZYME ACTIVITY; HUMAN; NONHUMAN; PROTEIN DEGRADATION; ANIMAL; MAMMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; ARGININE; MAMMALS;

EID: 85006978392     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.226621     Document Type: Article

References (121)

1. Morris SM Jr. Arginine: beyond protein. Am J Clin Nutr 2006;83 (Suppl):508S-12S.
2. Boudko DY. Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci 2007;851:186-210.
3. van Eijk HM, Luiking YC, Deutz NE. Methods using stable isotopes to measure nitric oxide (NO) synthesis in the L-arginine/NO pathway in health and disease. J Chromatogr B Analyt Technol Biomed Life Sci 2007;851:172-85.
4. Wu G, Meininger CJ. Analysis of citrulline, arginine, and methylarginines using high-performance liquid chromatography. Methods Enzymol 2008;440:177-89.
5. Martens-Lobenhoffer J, Bode-Boger SM. Mass spectrometric quantification of L-arginine and its pathway related substances in biofluids: the road to maturity. J Chromatogr B Analyt Technol Biomed Life Sci 2014;964:89-102.
6. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998;336:1-17.
7. Seiler N, Al-Therib MJ. Putrescine catabolism in mammalian brain. Biochem J 1974;144:29-35.
8. Yamasaki EN, Barbosa VD, De Mello FG, Hokoc JN. GABAergic system in the developing mammalian retina: dual sources of GABA at early stages of postnatal development. Int J Dev Neurosci 1999;17:201-13.
9. Kim JI, Ganesan S, Luo SX, Wu YW, Park E, Huang EJ, Chen L, Ding JB. Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons. Science 2015;350:102-6.
10. Mistry SK, Burwell TJ, Chambers RM, Rudolph-Owen L, Spaltmann F, Cook WJ, Morris SM Jr. Cloning of human agmatinase: an alternate path for polyamine synthesis induced in liver by hepatitis B virus. Am J Physiol Gastrointest Liver Physiol 2002;282:G375-81.
11. Jahan S, Davie JR. Protein arginine methyltransferases (PRMTs): role in chromatin organization. Adv Biol Regul 2015;57:173-84.
12. Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol Cell 2009;33:1-13.
13. Wei H, Mundade R, Lange KC, Lu T. Protein arginine methylation of non-histone proteins and its role in diseases. Cell Cycle 2014;13:32-41.
14. Hu RG, Brower CS, Wang H, Davydov IV, Sheng J, Zhou J, Kwon YT, Varshavsky A. Arginyltransferase, its specificity, putative substrates, bidirectional promoter, and splicing-derived isoforms. J Biol Chem 2006;281:32559-73.
15. Kashina AS. Protein arginylation: over 50 years of discovery. Methods Mol Biol 2015;1337:1-11.
16. Wang J, Han X, Wong CC, Cheng H, Aslanian A, Xu T, Leavis P, Roder H, Hedstrom L, Yates JR III, et al. Arginyltransferase ATE1 catalyzes midchain arginylation of proteins at side chain carboxylates in vivo. Chem Biol 2014;21:331-7.
17. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. BioEssays 2003;25:1106-18.
18. Sell DR, Monnier VM. Conversion of arginine into ornithine by advanced glycation in senescent human collagen and lens crystallins. J Biol Chem 2004;279:54173-84.
19. Morris SM Jr. Arginine metabolism: boundaries of our knowledge. J Nutr 2007;137(Suppl):1602S-9S.
20. Wu Z, Hou Y, Hu S, Bazer FW, Meininger CJ, McNeal CJ, Wu G. Catabolism and safety of supplemental L-arginine in animals. Amino Acids 2016;48:1541-52.
21. McNeal CJ, Meininger CJ, Reddy D, Wilborn CD, Wu G. Safety and effectiveness of arginine in adults. J Nutr 2016;146(Suppl):2587S-93S.
22. Rosenthal MD, Carrott PW, Patel J, Kiraly L, Martindale RG. Parenteral or enteral arginine supplementation safety and efficacy. J Nutr 2016;146(Suppl):2594S-600S.
23. Peranzoni E, Marigo I, Dolcetti L, Ugel S, Sonda N, Taschin E, Mantelli B, Bronte V, Zanovello P. Role of arginine metabolism in immunity and immunopathology. Immunobiology 2007;212:795-812.
24. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, Carey Satterfield M, Smith SB, Spencer TE, Yin Y. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009;37:153-68.
25. Morris SM Jr. Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol 2009;157:922-30.
26. Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 2009;158:638-51.
27. Haines RJ, Pendleton LC, Eichler DC. Argininosuccinate synthase: at the center of arginine metabolism. Int J Biochem Mol Biol 2011;2:8-23.
28. Luiking YC, Ten Have GA, Wolfe RR, Deutz NE. Arginine de novo and nitric oxide production in disease states. Am J Physiol Endocrinol Metab 2012;303:E1177-89.
29. Bahri S, Zerrouk N, Aussel C, Moinard C, Crenn P, Curis E, Chaumeil JC, Cynober L, Sfar S. Citrulline: from metabolism to therapeutic use. Nutrition 2013;29:479-84.
30. Popolo A, Adesso S, Pinto A, Autore G, Marzocco S. L-Arginine and its metabolites in kidney and cardiovascular disease. Amino Acids 2014;46:2271-86.
31. Breuillard C, Cynober L, Moinard C. Citrulline and nitrogen homeostasis: an overview. Amino Acids 2015;47:685-91.
32. Feun LG, Kuo MT, Savaraj N. Arginine deprivation in cancer therapy. Curr Opin Clin Nutr Metab Care 2015;18:78-82.
33. Monné M, Miniero DV, Daddabbo L, Palmieri L, Porcelli V, Palmieri F. Mitochondrial transporters for ornithine and related amino acids: a review. Amino Acids 2015;47:1763-77.
34. Qiu F, Huang J, Sui M. Targeting arginine metabolism pathway to treat arginine-dependent cancers. Cancer Lett 2015;364:1-7.
35. Kayacelebi AA, Langen J, Weigt-Usinger K, Chobanyan-Jurgens K, Mariotti F, Schneider JY, Rothmann S, Frolich JC, Atzler D, Choe CU, et al. Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free L-arginine in humans. Amino Acids 2015;47:1893-908.
36. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999;43: 542-8.
37. Blackwell S. The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine. Ann Clin Biochem 2010;47:17-28.
38. Schwedhelm E, Boger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol 2011;7:275-85.
39. Raptis V, Kapoulas S, Grekas D. Role of asymmetrical dimethylarginine in the progression of renal disease. Nephrology (Carlton) 2013;18:11-21.
40. Brinkmann SJ, de Boer MC, Buijs N, van Leeuwen PA. Asymmetric dimethylarginine and critical illness. Curr Opin Clin Nutr Metab Care 2014;17:90-7.
41. Lüneburg N, Xanthakis V, Schwedhelm E, Sullivan LM, Maas R, Anderssohn M, Riederer U, Glazer NL, Vasan RS, Boger RH. Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort. J Nutr 2011;141:2186-90.
42. van der Zwan LP, Scheffer PG, Dekker JM, Stehouwer CD, Heine RJ, Teerlink T. Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-toinhibitor ratio: the Hoorn Study. Clin Sci (Lond) 2011;121:71-8.
43. Cardounel AJ, Cui H, Samouilov A, Johnson W, Kearns P, Tsai AL, Berka V, Zweier JL. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem 2007;282:879-87.44. Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness. Metabolism 2012;61:482-90.
44. Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness. Metabolism 2012;61:482-90
45. Davids M, Teerlink T. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells. Metabolism 2013;62:1455-61.
46. Ogawa T, Kimoto M, Sasaoka K. Purification and properties of a new enzyme, NG, NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 1989;264:10205-9.
47. Rodionov RN, Jarzebska N, Weiss N, Lentz SR. AGXT2: a promiscuous aminotransferase. Trends Pharmacol Sci 2014;35:575-82.
48. Pope AJ, Karrupiah K, Kearns PN, Xia Y, Cardounel AJ. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production. J Biol Chem 2009;284:35338-47.
49. Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Boger RH, Bache RJ, et al. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Arterioscler Thromb Vasc Biol 2011;31:1540-6.
50. Martens-Lobenhoffer J, Bode-Boger SM. Amino acid N-acetylation: metabolic elimination of symmetric dimethylarginine as symmetric N (alpha)-acetyldimethylarginine, determined in human plasma and urine by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2015;975:59-64.
51. Marini JC, Agarwal U, Didelija IC. Dietary arginine requirements for growth are dependent on the rate of citrulline production in mice. J Nutr 2015;145:1227-31.
52. Marini JC, Didelija IC, Fiorotto ML. Extrarenal citrulline disposal in mice with impaired renal function. Am J Physiol Renal Physiol 2014;307:F660-5.
53. Ligthart-Melis GC, Vermeulen MA, van Leeuwen PA, Deutz NE. Glutamine: precursor or nitrogen donor for citrulline synthesis? Am J Physiol Endocrinol Metab 2010;299:E683; author reply: E4.
54. Marini JC, Didelija IC, Castillo L, Lee B. Glutamine: precursor or nitrogen donor for citrulline synthesis? Am J Physiol Endocrinol Metab 2010;299:E69-79.
55. Marini JC, Didelija IC, Lee B. Reply to Ligthart-Melis et al [letter]. Am J Physiol Endocrinol Metab 2010;299:E684.
56. Ligthart-Melis GC, Marini JC, Engelen MP, Deutz NE. Glutamine supplementation, citrulline production, and de novo arginine synthesis: is there a relation? Am J Clin Nutr 2015;101:890-2.
57. Buijs N, Brinkmann SJ, Oosterink JE, Luttikhold J, Schierbeek H, Wisselink W, Beishuizen A, van Goudoever JB, Houdijk AP, van Leeuwen PA, et al. Reply to GC Ligthart-Melis et al [letter]. Am J Clin Nutr 2015;101:892-3.
58. Tomlinson C, Rafii M, Ball RO, Pencharz P. Arginine synthesis from enteral glutamine in healthy adults in the fed state. Am J Physiol Endocrinol Metab 2011;301:E267-73.
59. Tomlinson C, Rafii M, Ball RO, Pencharz PB. Arginine can be synthesized from enteral proline in healthy adult humans. J Nutr 2011;141:1432-6.
60. Ligthart-Melis GC, van de Poll MC, Boelens PG, Dejong CH, Deutz NE, van Leeuwen PA. Glutamine is an important precursor for de novo synthesis of arginine in humans. Am J Clin Nutr 2008;87:1282-9.
61. Marini JC. Arginine and ornithine are the main precursors for citrulline synthesis in mice. J Nutr 2012;142:572-80.
62. Marini JC. Interrelationships between glutamine and citrulline metabolism. Curr Opin Clin Nutr Metab Care 2016;19:62-6.
63. Cheung CW, Cohen NS, Raijman L. Channeling of urea cycle intermediates in situ in permeabilized hepatocytes. J Biol Chem 1989;264:4038-44.
64. Pastor CM, Morris SM Jr., Billiar TR. Sources of arginine for induced nitric oxide synthesis in the isolated perfused liver. Am J Physiol 1995;269:G861-6.
65. Simon A, Plies L, Habermeier A, Martine U, ReiningM, Closs EI. Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells. Circ Res 2003;93:813-20.
66. Goodwin BL, Solomonson LP, Eichler DC. Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J Biol Chem 2004;279:18353-60.
67. Topal G, Brunet A, Walch L, Boucher JL, David-Dufilho M. Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. J Pharmacol Exp Ther 2006;318:1368-74. Erratum in: J Pharmacol Exp Ther 2006;319(1):506.
68. Karbach S, Simon A, Slenzka A, Jaenecke I, Habermeier A, Martine U, Forstermann U, Closs EI. Relative contribution of different l-arginine sources to the substrate supply of endothelial nitric oxide synthase. J Mol Cell Cardiol 2011;51:855-61.
69. Shen LJ, Beloussow K, Shen WC. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem Pharmacol 2005;69:97-104.
70. Closs EI, Simon A, Vekony N, Rotmann A. Plasma membrane transporters for arginine. J Nutr 2004;134(Suppl):2752S-9S; discussion: 65S-67S.
71. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y. CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch 2004;447:532-42.
72. Closs EI, Boissel JP, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs). J Membr Biol 2006;213:67-77.
73. Simon A, Karbach S, Habermeier A, Closs EI. Decoding the substrate supply to human neuronal nitric oxide synthase. PLoS One 2013;8: e67707.
74. Qualls JE, Subramanian C, Rafi W, Smith AM, Balouzian L, DeFreitas AA, Shirey KA, Reutterer B, Kernbauer E, Stockinger S, et al. Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1. Cell Host Microbe 2012;12:313-23.
75. Rapovy SM, Zhao J, Bricker RL, Schmidt SM, Setchell KD, Qualls JE. Differential requirements for L-citrulline and L-arginine during antimycobacterial macrophage activity. J Immunol 2015;195:3293-300.
76. Fakler CR, Kaftan HA, Nelin LD. Two cases suggesting a role for the L-arginine nitric oxide pathway in neonatal blood pressure regulation. Acta Paediatr 1995;84:460-2.
77. Brunetti-Pierri N, Erez A, Shchelochkov O, Craigen W, Lee B. Systemic hypertension in two patients with ASL deficiency: a result of nitric oxide deficiency? Mol Genet Metab 2009;98:195-7.
78. Erez A, Nagamani SC, Shchelochkov OA, Premkumar MH, Campeau PM, Chen Y, Garg HK, Li L, Mian A, Bertin TK, et al. Requirement of argininosuccinate lyase for systemic nitric oxide production. Nat Med 2011;17:1619-26.
79. Su Y. Regulation of endothelial nitric oxide synthase activity by protein-protein interaction. Curr Pharm Des 2014;20:3514-20.
80. Xiong Y, Yu Y, Montani JP, Yang Z, Ming XF. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its L-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability. J Am Heart Assoc 2013;2:e000096.
81. Xiong Y, Yepuri G, Forbiteh M, Yu Y, Montani JP, Yang Z, Ming XF. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis. Autophagy 2014;10:2223-38.
82. DavidsM, Ndika JD, Salomons GS, Blom HJ, Teerlink T. Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine. FEBS Lett 2012;586:3653-7.
83. Choe CU, Atzler D, Wild PS, Carter AM, Boger RH, Ojeda F, Simova O, Stockebrand M, Lackner K, Nabuurs C, et al. Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation 2013;128:1451-61.
84. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, Bohm BO, Ritz E, et al. Homoarginine, cardiovascular risk, and mortality. Circulation 2010;122:967-75.
85. Atzler D, Mieth M, Maas R, Boger RH, Schwedhelm E. Stable isotope dilution assay for liquid chromatography-tandem mass spectrometric determination of L-homoarginine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:2294-8.
86. Jázwínska-Kozuba A, Martens-Lobenhoffer J, Kruszelnicka O, Rycaj J, Chyrchel B, Surdacki A, Bode-Boger SM. Opposite associations of plasma homoarginine and ornithine with arginine in healthy children and adolescents. Int J Mol Sci 2013;14:21819-32.
87. Kayacelebi AA, Beckmann B, Gutzki FM, Jordan J, Tsikas D. GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples. Amino Acids 2014; 46:2205-17.
88. May M, Kayacelebi AA, Batkai S, Jordan J, Tsikas D, Engeli S. Plasma and tissue homoarginine concentrations in healthy and obese humans. Amino Acids 2015;47:1847-52.
89. Pilz S, Meinitzer A, Tomaschitz A, Drechsler C, Ritz E, Krane V, Wanner C, Boehm BO, Marz W. Low homoarginine concentration is a novel risk factor for heart disease. Heart 2011;97:1222-7.
90. Atzler D, Gore MO, Ayers CR, Choe CU, Boger RH, de Lemos JA, McGuire DK, Schwedhelm E. Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study. Arterioscler Thromb Vasc Biol 2014;34:2501-7.
91. Pilz S, Teerlink T, Scheffer PG, Meinitzer A, Rutters F, Tomaschitz A, Drechsler C, Kienreich K, Nijpels G, Stehouwer CD, et al. Homoarginine and mortality in an older population: the Hoorn study. Eur J Clin Invest 2014;44:200-8.
92. Atzler D, Schwedhelm E, Choe CU. L-homoarginine and cardiovascular disease. Curr Opin Clin Nutr Metab Care 2015;18: 83-8.
93. Pilz S, Meinitzer A, Gaksch M, Grubler M, Verheyen N, Drechsler C, Hartaigh BO, Lang F, Alesutan I, Voelkl J, et al. Homoarginine in the renal and cardiovascular systems. Amino Acids 2015;47:1703-13.
94. Tsikas D, Wu G. Homoarginine, arginine, and relatives: analysis, metabolism, transport, physiology, and pathology. Amino Acids 2015;47:1697-702.
95. Hecker M, Walsh DT, Vane JR. On the substrate specificity of nitric oxide synthase. FEBS Lett 1991;294:221-4.
96. Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D. Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine. Biochemistry 1998;37:10453-60.
97. Reczkowski RS, Ash DE. Rat liver arginase: kinetic mechanism, alternate substrates, and inhibitors. Arch Biochem Biophys 1994;312:31-7.
98. Efeyan A, Comb WC, Sabatini DM. Nutrient-sensing mechanisms and pathways. Nature 2015;517:302-10.
99. Gallinetti J, Harputlugil E, Mitchell JR. Amino acid sensing in dietaryrestriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. Biochem J 2013;449:1-10.
100. Lee J, Ryu H, Ferrante RJ, Morris SM Jr., Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci USA 2003;100: 4843-8.
101. Fernandez J, Yaman I, Sarnow P, Snider MD, Hatzoglou M. Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2alpha. J Biol Chem 2002;277:19198-205.
102. Hatzoglou M, Fernandez J, Yaman I, Closs E. Regulation of cationic amino acid transport: the story of the CAT-1 transporter. Annu Rev Nutr 2004;24:377-99.
103. Kimball SR, Jefferson LS. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr 2006;136(Suppl):227S-31S.
104. Ban H, Shigemitsu K, Yamatsuji T, Haisa M, Nakajo T, Takaoka M, Nobuhisa T, Gunduz M, Tanaka N, Naomoto Y. Arginine and leucine regulate p70 S6 kinase and 4E-BP1 in intestinal epithelial cells. Int J Mol Med 2004;13:537-43.
105. Nakajo T, Yamatsuji T, Ban H, Shigemitsu K, Haisa M, Motoki T, Noma K, Nobuhisa T, Matsuoka J, Gunduz M, et al. Glutamine is a key regulator for amino acid-controlled cell growth through the mTOR signaling pathway in rat intestinal epithelial cells. Biochem Biophys Res Commun 2005;326:174-80.
106. Bauchart-Thevret C, Cui L, Wu G, Burrin DG. Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide. Am J Physiol Endocrinol Metab 2010;299:E899-909.
107. Wauson EM, Guerra ML, Dyachok J, McGlynn K, Giles J, Ross EM, Cobb MH. Differential regulation of ERK1/2 and mTORC1 through T1R1/T1R3 in MIN6 cells. Mol Endocrinol 2015;29:1114-22.
108. Wauson EM, Zaganjor E, Lee AY, Guerra ML, Ghosh AB, Bookout AL, Chambers CP, Jivan A, McGlynn K, Hutchison MR, et al. The G protein-coupled taste receptor T1R1/T1R3 regulates mTORC1 and autophagy. Mol Cell 2012;47:851-62.
109. Nelson G, Chandrashekar J, Hoon MA, Feng L, Zhao G, Ryba NJ, Zuker CS. An amino-acid taste receptor. Nature 2002;416:199-202.
110. Toda Y, Nakagita T, Hayakawa T, Okada S, Narukawa M, Imai H, Ishimaru Y, Misaka T. Two distinct determinants of ligand specificity in T1R1/T1R3 (the umami taste receptor). J Biol Chem 2013;288: 36863-77.
111. Wang S, Tsun ZY, Wolfson RL, Shen K, Wyant GA, Plovanich ME, Yuan ED, Jones TD, Chantranupong L, Comb W, et al. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 2015;347:188-94.
112. Rebsamen M, Pochini L, Stasyk T, de Araujo ME, Galluccio M, Kandasamy RK, Snijder B, Fauster A, Rudashevskaya EL, Bruckner M, et al. SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. Nature 2015;519:477-81.
113. Kuang D, Yao Y, Lam J, Tsushima RG, Hampson DR. Cloning and characterization of a family C orphan G-protein coupled receptor. J Neurochem 2005;93:383-91.
114. Wellendorph P, Hansen KB, Balsgaard A, Greenwood JR, Egebjerg J, Brauner-Osborne H. Deorphanization of GPRC6A: a promiscuous L-alpha-amino acid receptor with preference for basic amino acids. Mol Pharmacol 2005;67:589-97.
115. Conigrave AD, Hampson DR. Broad-spectrum L-amino acid sensing by class 3 G-protein-coupled receptors. Trends Endocrinol Metab 2006;17:398-407.
116. Pi M, Quarles LD. Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks. Endocrinology 2012;153:2062-9.
117. Wauson EM, Lorente-Rodriguez A, Cobb MH. Minireview: nutrient sensing by G protein-coupled receptors. Mol Endocrinol 2013; 27:1188-97.
118. Clemmensen C, Smajilovic S, Wellendorph P, Brauner-Osborne H. The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function. Br J Pharmacol 2014;171:1129-41.
119. Mills E, Petersen E, Kulasekara BR, Miller SI. A direct screen for c-di-GMP modulators reveals a Salmonella Typhimurium periplasmic L-arginine-sensing pathway. Sci Signal 2015;8:ra57.
120. Römling U. Small molecules with big effects: cyclic di-GMP-mediated stimulation of cellulose production by the amino acid L-arginine. Sci Signal 2015;8:fs12.
121. Chantranupong L, Scaria SM, Saxton RA, Gygi MP, Shen K, Wyant GA, Wang T, Harper JW, Gygi SP, Sabatini DM. The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway. Cell 2016;165:153-64.